OR WAIT null SECS
February 14, 2020
The company has said that all three of its operating sites in China started back up on Feb. 12 and that it is closely monitoring the outbreak.
January 02, 2020
Aurobindo Pharma USA, Inc. voluntarily recalled Mirtazapine Tablets due to an error on the label that listed the incorrect strength.
December 18, 2019
Glenmark Pharmaceuticals is recalling unexpired lots of Ranitidine Tablets due to potential presence of N-nitrosodimethylamine (NDMA).
December 12, 2019
According to a consent decree of permanent injunction issued in September 2019, the health and wellness companies must recall and stop distributing products until the companies comply with the Federal Food, Drug, and Cosmetic Act and other requirements included in the consent decree.
October 28, 2019
The company is recalling Alprazolam Tablets, USP C-IV 0.5 mg because of potential presence of foreign substance.
October 24, 2019
Pfizer has issued a voluntary recall of batches of its docetaxel injection 80 mg/8 mL due to impurity concerns.
Dr. Reddy’s, Sanofi, and Perrigo Company issued voluntary recalls of ranitidine in October 2019 because of N-Nitrosodimethylamine contamination.
October 02, 2019
The root cause of NDMA contamination may go well beyond manufacturing problems, to the molecule itself.
September 16, 2019
EMA plans to issue new guidance, as US and European regulators respond to reports of nitrosamine contamination in H2 blockers, including Zantac, that contain rantidine.
September 11, 2019
FDA issued a statement about the importance of reporting adverse events resulting from the use of compounded drugs.